EUVIMEDEUVIMED entdecken
Crossref

Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder

Mariana Fernandes, Silvia Maio, Paolo Eusebi iD, Fabio Placidi, Francesca Izzi, Matteo Spanetta, Claudia De Masi, Clementina Lupo, Carmen Calvello, Marzia Nuccetelli, Sergio Bernardini, Nicola Biagio Mercuri und 1 weitere

SLEEP · 2024

DOI: 10.1093/sleep/zsad198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SLEEP, 2024. Verfasst von Mariana Fernandes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine, University of Rome 'Tor Vergata", Rome, Italy. Hauptthemen laut MEDLINE: Synucleinopathies, REM Sleep Behavior Disorder, Parkinson Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Objectives Patients with isolated rapid-eye-movement sleep behavior disorder (iRBD) have an increased risk of developing neurodegenerative diseases. This study assessed cerebrospinal-fluid (CSF) biomarkers of neurodegeneration and blood-brain barrier (BBB) alteration in patients with iRBD compared to controls and ascertain whether these biomarkers may predict phenoconversion to alpha-synucleinopathies (Parkinson’s Disease (PD), Dementia with Lewy bodies (DLB), Multiple System Atrophy (MSA)).

Methods

Patients and controls underwent between 2012 and 2016 a neurological assessment, a lumbar puncture for CSF biomarker analysis (β-amyloid42 - Aβ42; total-tau, and phosphorylated tau), and BBB alteration (CSF/serum albumin ratio). All patients with iRBD were followed until 2021 and then classified into patients who converted to alpha-synucleinopathies (iRBD converters, cRBD) or not (iRBD non-converters, ncRBD).

Results

Thirty-four patients with iRBD (mean age 67.12 ± 8.14) and 33 controls (mean age 64.97 ± 8.91) were included. At follow-up (7.63 ± 3.40 years), eight patients were ncRBD and 33 patients were cRBD: eleven converted to PD, 10 to DLB, and two to MSA. Patients with iRBD showed lower CSF Aβ42 levels and higher CSF/serum albumin ratio than controls. Cox regression analysis showed that the phenoconversion rate increases with higher motor impairment (hazard ratio [HR] = 1.23, p = 0.032). CSF Aβ42 levels predicted phenoconversion to DLB (HR = 0.67, p = 0.038) and BBB alteration predicted phenoconversion to PD (HR = 1.20, p = 0.038).

Discussion

This study showed that low CSF Aβ42 levels and high BBB alteration may predict the phenoconversion to DLB and PD in patients with iRBD, respectively. These findings highlight the possibility to discriminate phenoconversion in iRBD patients through CSF biomarkers; however, further studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynucleinopathiesREM Sleep Behavior DisorderParkinson DiseaseHumansMiddle AgedAgedEye MovementsBiomarkersSerum AlbuminSleep

Stichwörter der Autor:innen

REM sleep behavior disorderalpha-synucleinopathiesbiomarkerslongitudinalneurogenerative disorders

Substanzen

BiomarkersSerum Albumin

Autor:innen und Institutionen

  • Department of Systems Medicine, University of Rome 'Tor Vergata", Rome, Italy.
  • Sleep Medicine Centre, Neurology Unit, University Hospital "Tor Vergata", Rome, Italy.
  • Department of Medicine, Neurology Clinic, University Hospital of Perugia, Italy.
  • Department of Clinical Biochemistry and Molecular Biology, University of Rome "Tor Vergata", Rome, Italy.

ORCID-Profile: Paolo Eusebi, Claudio Liguori

Zitieren

APA

Fernandes, M., Maio, S., Eusebi, P., Placidi, F., Izzi, F., Spanetta, M., De Masi, C., Lupo, C., Calvello, C., Nuccetelli, M., Bernardini, S., Mercuri, N. B., & Liguori, C. (2024). Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder. SLEEP. https://doi.org/10.1093/sleep/zsad198

Vancouver

Fernandes M, Maio S, Eusebi P, Placidi F, Izzi F, Spanetta M, et al. Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder. SLEEP. 2024. doi:10.1093/sleep/zsad198

BibTeX
@article{Fernandes2024,
  author = {Fernandes, Mariana and Maio, Silvia and Eusebi, Paolo and Placidi, Fabio and Izzi, Francesca and Spanetta, Matteo and De Masi, Claudia and Lupo, Clementina and Calvello, Carmen and Nuccetelli, Marzia and Bernardini, Sergio and Mercuri, Nicola Biagio and Liguori, Claudio},
  title = {Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder},
  journal = {SLEEP},
  year = {2024},
  doi = {10.1093/sleep/zsad198}
}
Kostenlos starten →